Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care
-
Published:2021-12
Issue:
Volume:159
Page:38-51
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Garreffa EmanueleORCID,
Hamad AhmedORCID,
O'Sullivan Ciara C.,
Hazim Antonious Z.ORCID,
York JoanneORCID,
Puri Shama,
Turnbull Anne,
Robertson John F.,
Goetz Matthew P.
Subject
Cancer Research,Oncology
Reference38 articles.
1. Covid-19: booster vaccine to be rolled out in autumn as UK secures 60m more Pfizer doses;Mahase;BMJ,2021
2. Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial;Borobia;Lancet,2021
3. Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study;Hillus;Lancet Respir Med,2021
4. Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination;Schmidt;Nat Med,2021
5. Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination;Barros-Martins;Nat Med,2021
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献